Share capital and dividends

Nutri Pharma ASA is a public limited company under Norwegian law. Incorporated in January 1993, it was listed on the Oslo Stock Exchange in May 2000. The Nutri Pharma share is registered in the Norwegian Central Securities Depository (VPS) and listed on the Oslo Stock Exchange, under the ticker code NUT.

Nutri Pharma’s goal of creating value for its shareholders means a continuous focus on ensuring that the company’s balance sheet and its financing - inclusive of its equity - is adapted to the company’s objectives, strategy and risk profile .

The company has financed its expansion into distribution and new markets through compensation in Nutri Pharma shares. The current business model requires relatively low capital and the emphasis is on organic growth. The Board of Directors constantly assesses the company’s need for financial strength related to goals, strategy and risk profile.

The Board of Directors has adopted a financial policy that has targeted an equity ratio (book equity in percent of total assets) of no less than 30 per cent. The company favors a dividend policy based on financial performance, but the increase in share price should, over time, account for the largest part of the return on shareholder investment. When appropriate, and particularly when the share price is considered low, the company aims to buy back its own shares from the market.

The shareholders have the opportunity through the annual general meeting to approve any mandate to the Board of Directors to issue shares or purchase own shares. At present the shareholders have approved a mandate to purchase own shares, and there is a mandate to issue 18 million new shares.